Create a free QxMD account to receive personalized paper recommendations, relevant to your practice.

JOURNAL ARTICLE

Reaction of anti-Gd, anti-Fl and anti-Sa cold agglutinins with p erythrocytes

D Roelcke

Vox Sanguinis 1984, 46 (3): 161-4

Among four anti-Gd cold agglutinins two showed a slight preferential reaction with p erythrocytes, two did not. Anti-Fl and anti-Sa cold agglutinins, sharing some serologic characteristics with Gd antibodies, showed no preferential reactions with p cells. The findings point to different fine specificities of monoclonal anti-Gd cold agglutinins.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Trending Papers

Albumin administration in patients with cirrhosis: Current role and novel perspectives. Ângelo Zambam de Mattos, Douglas Alano Simonetto, Carlos Terra, Alberto Queiroz Farias, Paulo Lisboa Bittencourt, Tales Henrique Soares Pase, Marlon Rubini Toazza, Angelo Alves de Mattos World Journal of Gastroenterology: WJG 2022 September 7, 28 (33): 4773-4786

Poststroke Seizure and Epilepsy: A Review of Incidence, Risk Factors, Diagnosis, Pathophysiology, and Pharmacological Therapies. Joseph Phan, Mario Ramos, Theodore Soares, Mayur S Parmar Oxidative Medicine and Cellular Longevity 2022, 2022: 7692215

Management of chronic migraine. Alexandra Hovaguimian, Julie Roth BMJ: British Medical Journal 2022 October 10, 379: e067670

Which crystalloid should we be using for the resuscitation of septic patients? Doran Drew, Ariel Hendin, Debra Eagles CJEM 2022 November 11

Myelofibrosis. Francesco Passamonti, Barbara Mora Blood 2022 November 23

Urticaria. Pavel Kolkhir, Ana M Giménez-Arnau, Kanokvalai Kulthanan, Jonny Peter, Martin Metz, Marcus Maurer Nature Reviews. Disease Primers 2022 September 15, 8 (1): 61

Levothyroxine: Conventional and novel drug delivery formulations. Hanqing Liu, Wei Li, Wen Zhang, Shengrong Sun, Chuang Chen Endocrine Reviews 2022 November 22

Sodium-Glucose Cotransporter-2 Inhibitors-Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials. Tomohito Gohda, Maki Murakoshi International Journal of Molecular Sciences 2022 November 9, 23 (22)

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Reaction of anti-Gd, anti-Fl and anti-Sa cold agglutinins with p erythrocytes

Discussion

Trending Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips